Home›Companies›Biotech & Pharma›Haku Bio

Haku Bio, Inc.

No website or LinkedIn page we could confirm. Why?
Updated Nov 10, 2026·Latest SEC filing Jun 10, 2026·Suggest an edit

About Haku Bio

Haku Bio is a private company based in Arlington, Massachusetts, incorporated in 2026 in Delaware. It has reported $1,719,000 raised in two offerings on Form D since March 2026. Its chief executive is Sandy Mong.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
May 22, 2026Jun 10, 2026amended Jun 10, 2026$1,509,000of $2.7M target6$251KSimple Agreement for Future Equity (SAFE)Rule 506(b)Form D/A ↗1 earlier filing
Feb 9, 2026Mar 2, 2026$210,000target not set2$105KDebtRule 506(b)Form D ↗
Total, two offerings$1,719,000

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on Haku Bio's Form D filed Jun 10, 2026.

BL
SM
Sandy Mong
CEO and director

Sources

  1. SECHaku Bio, Inc. Form D, filed Jun 10, 2026
  2. SECHaku Bio, Inc. filing history